Skip To Content
Bhumsuk Keam
Blog
Department

1   Hemato Oncology

2   Medical Oncology Center

Specialty

1   Head and neck cancer , Lung cancer , esophageal cancer

2   Head and neck cancer , Lung cancer , esophageal cancer , Clinical trial , Personalized treatment

Appointment
researchgateUrl scholarUrl orcidUrl

Education / Career

Education / Career
Article Effects of percutaneous injection laryngoplasty on voice and swallowing problems in cancer-related unilateral vocal cord paralysis.
Announcements LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY Date of publication 2021-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34401505/
Education / Career
Article Cabozantinib for radioiodine-refractory differentiated thyroid cancer (cosmic-311): a randomised, double-blind, placebo-controlled, phase 3 trial.
Announcements LANCET ONCOLOGY Date of publication 2021-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34237250/
Education / Career
Article A phase ii study of brentuximab vedotin in patients with relapsed or refractory epstein-barr virus-positive and cd30-positive lymphomas.
Announcements HAEMATOLOGICA Date of publication 2021-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33792222/
Education / Career
Article Cancer patients' willingness to take covid-19 vaccination: a nationwide multicenter survey in korea.
Announcements CANCERS Date of publication 2021-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34359783/
Education / Career
Article Korean version of the patient dignity inventory: translation and validation in patients with advanced cancer.
Announcements JOURNAL OF PAIN AND SYMPTOM MANAGEMENT Date of publication 2021-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33484796/
Education / Career
Article Pralsetinib for patients with advanced or metastatic ret-altered thyroid cancer (arrow): a multi-cohort, open-label, registrational, phase 1/2 study.
Announcements LANCET DIABETES & ENDOCRINOLOGY Date of publication 2021-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34118198/
Education / Career
Article Randomized phase ii study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma.
Announcements CLINICAL CANCER RESEARCH Date of publication 2021-7
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34315722/
Education / Career
Article Outcomes and biomarkers of immune checkpoint inhibitor therapy in patients with refractory head and neck squamous cell carcinoma: kcsg hn18-12.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2021-7
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33285051/
Education / Career
Article Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer.
Announcements KOREAN JOURNAL OF INTERNAL MEDICINE Date of publication 2021-7
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32872743/
Education / Career
Article Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy.
Announcements CANCER IMMUNOLOGY IMMUNOTHERAPY Date of publication 2021-6
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33230567/
Education / Career
Article Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues.
Announcements CANCER IMMUNOLOGY IMMUNOTHERAPY Date of publication 2021-6
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33389015/
Education / Career
Article Difficulties doctors experience during life-sustaining treatment discussion after enactment of the life-sustaining treatment decisions act: a cross-sectional study.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2021-4
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33211941/
Education / Career
Article Genotypic and phenotypic characteristics of hereditary leiomyomatosis and renal cell cancer syndrome in korean patients.
Announcements ANNALS OF LABORATORY MEDICINE Date of publication 2021-3
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33063682/
Education / Career
Article Tumor lag-3 and ny-eso-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Announcements THORACIC CANCER Date of publication 2021-3
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33458968/
Education / Career
Article Pan-asian adaptation of the ehns-esmo-estro clinical practice guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.
Announcements ESMO OPEN Date of publication 2021-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34844180/
Education / Career
Article Programmed death-ligand 1 expression level as a predictor of egfr tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
Announcements TRANSLATIONAL LUNG CANCER RESEARCH Date of publication 2021-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33718015/
Education / Career
Article A phase i study of imc-001, a pd-l1 blocker, in patients with metastatic or locally advanced solid tumors.
Announcements INVESTIGATIONAL NEW DRUGS Date of publication 2021-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34268711/
Education / Career
Article Care for critically and terminally ill patients and moral distress of physicians and nurses in tertiary hospitals in south korea: a qualitative study.
Announcements PLOS ONE Date of publication 2021-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34914723/
Education / Career
Article Newly identified members of fibroblast growth factor receptor 1 splice variants engage in crosstalk with the axl/akt axis in salivary adenoid cystic carcinoma.
Announcements CANCER RESEARCH Date of publication 2021-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33408119/
Education / Career
Article Acquired resistance to third-generation egfr tyrosine kinase inhibitors in patients with de novo egfr(t790m)-mutant nsclc.
Announcements JOURNAL OF THORACIC ONCOLOGY Date of publication 2021-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34242789/
Education / Career
Article Therapeutic implications of activating noncanonical pik3ca mutations in head and neck squamous cell carcinoma.
Announcements JOURNAL OF CLINICAL INVESTIGATION Date of publication 2021-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34779417/
Education / Career
Article Impact of family caregivers' awareness of the prognosis on their quality of life/depression and those of patients with advanced cancer: a prospective cohort study.
Announcements SUPPORTIVE CARE IN CANCER Date of publication 2021-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32372177/
Education / Career
Article Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma.
Announcements KOREAN JOURNAL OF INTERNAL MEDICINE Date of publication 2021-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32218101/
Education / Career
Article Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Announcements SCIENTIFIC REPORTS Date of publication 2021-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33510255/
Education / Career
Article Soluble pd-l1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment.
Announcements SCIENTIFIC REPORTS Date of publication 2021-0
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/34611279/
Education / Career
Article Real-world clinical outcomes and prognostic factors for patients with advanced angiosarcoma who received systemic treatment.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2021-0
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33540493/
Education / Career
Article Squamous cell carcinoma of head and neck: what internists should know.
Announcements KOREAN JOURNAL OF INTERNAL MEDICINE Date of publication 2020-9
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32663913/
Education / Career
Article Anti-tumor effects of nk cells and anti-pd-l1 antibody with antibody-dependent cellular cytotoxicity in pd-l1-positive cancer cell lines.
Announcements JOURNAL FOR IMMUNOTHERAPY OF CANCER Date of publication 2020-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32830112/
Education / Career
Article Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (kcsg hn13-01).
Announcements BMC CANCER Date of publication 2020-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32854649/
Education / Career
Article A multicenter, phase i, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment.
Announcements PHARMACOLOGY RESEARCH & PERSPECTIVES Date of publication 2020-8
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32567817/
Education / Career
Article Implication of the life-sustaining treatment decisions act on end-of-life care for korean terminal patients.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2020-7
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32204581/
Education / Career
Article Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors.
Announcements CLINICAL INFECTIOUS DISEASES Date of publication 2020-7
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/31680143/
Education / Career
Article Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: eagle, a randomized, open-label phase iii study.
Announcements ANNALS OF ONCOLOGY Date of publication 2020-7
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32294530/
Education / Career
Article Phase ia/ib study of single-agent tislelizumab, an investigational anti-pd-1 antibody, in solid tumors.
Announcements JOURNAL FOR IMMUNOTHERAPY OF CANCER Date of publication 2020-6
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32540858/
Education / Career
Article Gene signature for sorafenib susceptibility in hepatocellular carcinoma: different approach with a predictive biomarker.
Announcements LIVER CANCER Date of publication 2020-4
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32399432/
Education / Career
Article A phase 1 study of oral asp5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignancies.
Announcements INVESTIGATIONAL NEW DRUGS Date of publication 2020-4
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/31041575/
Education / Career
Article Clinical application of next-generation sequencing-based panel to braf wild-type advanced melanoma identifies key oncogenic alterations and therapeutic strategies.
Announcements MOLECULAR CANCER THERAPEUTICS Date of publication 2020-3
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/31826932/
Education / Career
Article Severe late dysphagia after multimodal treatment of stage iii/iv laryngeal and hypopharyngeal cancer.
Announcements JAPANESE JOURNAL OF CLINICAL ONCOLOGY Date of publication 2020-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/31711185/
Education / Career
Article Phase ii study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: kcsg-lu16-07.
Announcements THORACIC CANCER Date of publication 2020-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33026712/
Education / Career
Article Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: korean cancer study group hn 18-12.
Announcements JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY Date of publication 2020-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32671504/
Education / Career
Article Combined blockade of polo-like kinase and pan-raf is effective against nras-mutant non-small cell lung cancer cells.
Announcements CANCER LETTERS Date of publication 2020-2
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32979462/
Education / Career
Article Cell-mediated immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors.
Announcements JOURNAL OF INFECTIOUS DISEASES Date of publication 2020-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32479600/
Education / Career
Article The impacts of prognostic awareness on mood and quality of life among patients with advanced cancer.
Announcements AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE Date of publication 2020-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32052654/
Education / Career
Article Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data.
Announcements ANNALS OF TRANSLATIONAL MEDICINE Date of publication 2020-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33313134/
Education / Career
Article Hla-b27 association of autoimmune encephalitis induced by pd-l1 inhibitor.
Announcements ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY Date of publication 2020-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/33031633/
Education / Career
Article Efficacy and tolerability of tremelimumab in locally advanced or metastatic urothelial carcinoma patients who have failed first-line platinum-based chemotherapy.
Announcements CLINICAL CANCER RESEARCH Date of publication 2020-1
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/31801732/
Education / Career
Article Safety and clinical activity of medi0562, a humanized ox40 agonist monoclonal antibody, in adult patients with advanced solid tumors.
Announcements CLINICAL CANCER RESEARCH Date of publication 2020-0
Co-researcher
Pubmed URL https://www.ncbi.nlm.nih.gov/pubmed/32816951/
Education / Career
Article Preclinical modeling of osimertinib for nsclc with egfr exon 20 insertion mutations.
Announcements JOURNAL OF THORACIC ONCOLOGY Date of publication 2019-9
Co-researcher
Education / Career
Article Clinical factors affecting progression-free survival with crizotinib in alk-positive non-small cell lung cancer.
Announcements KOREAN JOURNAL OF INTERNAL MEDICINE Date of publication 2019-9
Co-researcher
Education / Career
Article First-line pembrolizumab versus pembrolizumab plus chemotherapy versus chemotherapy alone in non-small-cell lung cancer: a systematic review and network meta-analysis.
Announcements CLINICAL LUNG CANCER Date of publication 2019-9
Co-researcher
Education / Career
Article Clinicopathological and preclinical findings of nut carcinoma: a multicenter study.
Announcements ONCOLOGIST Date of publication 2019-8
Co-researcher
Education / Career
Article Pemetrexed in the treatment of leptomeningeal metastasis in patients with egfr-mutant lung cancer.
Announcements CLINICAL LUNG CANCER Date of publication 2019-7
Co-researcher
Education / Career
Article Clinical significance of rituximab infusion-related reaction in diffuse large b-cell lymphoma patients receiving r-chop.
Announcements KOREAN JOURNAL OF INTERNAL MEDICINE Date of publication 2019-7
Co-researcher
Education / Career
Article Establishment of the seoul national university prospectively enrolled registry for genitourinary cancer (super-guc): a prospective, multidisciplinary, bio-bank linked cohort and research platform.
Announcements INVESTIGATIVE AND CLINICAL UROLOGY Date of publication 2019-7
Co-researcher
Education / Career
Article Alterations in pd-l1 expression associated with acquisition of resistance to alk inhibitors in alk-rearranged lung cancer.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2019-7
Co-researcher
Education / Career
Article Costs and clinical outcomes of patients with diffuse large b-cell lymphoma in first remission: role of pet/ct surveillance.
Announcements KOREAN JOURNAL OF INTERNAL MEDICINE Date of publication 2019-7
Co-researcher
Education / Career
Article Acquired resistance of met-amplified non-small cell lung cancer cells to the met inhibitor capmatinib.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2019-7
Co-researcher
Education / Career
Article A phase ii study of genexol-pm and cisplatin as induction chemotherapy in locally advanced head and neck squamous cell carcinoma.
Announcements ONCOLOGIST Date of publication 2019-6
Co-researcher
Education / Career
Article Nk92-cd16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors.
Announcements CYTOTHERAPY Date of publication 2019-6
Co-researcher
Education / Career
Article Safety and efficacy of immune checkpoint inhibitors for end-stage renal disease patients undergoing dialysis: a retrospective case series and literature review.
Announcements INVESTIGATIONAL NEW DRUGS Date of publication 2019-6
Co-researcher
Education / Career
Article Prognostic value of the association between mhc class i downregulation and pd-l1 upregulation in head and neck squamous cell carcinoma patients.
Announcements SCIENTIFIC REPORTS Date of publication 2019-5
Co-researcher
Education / Career
Article Pruritus in patients under targeted anticancer therapy: a multidimensional analysis using the 5-d itch scale.
Announcements ACTA DERMATO-VENEREOLOGICA Date of publication 2019-4
Co-researcher
Education / Career
Article Immune-checkpoint-inhibitor-induced severe autoimmune encephalitis treated by steroid and intravenous immunoglobulin.
Announcements JOURNAL OF CLINICAL NEUROLOGY Date of publication 2019-4
Co-researcher
Education / Career
Article Safety and antitumor activity of the anti-pd-1 antibody pembrolizumab in patients with advanced, pd-l1-positive papillary or follicular thyroid cancer.
Announcements BMC CANCER Date of publication 2019-3
Co-researcher
Education / Career
Article Efficacy of a decision aid consisting of a video and booklet on advance care planning for advanced cancer patients: randomized controlled trial.
Announcements JOURNAL OF PAIN AND SYMPTOM MANAGEMENT Date of publication 2019-2
Co-researcher
Education / Career
Article Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage iii/iv hypopharyngeal cancer: multicenter review of 266 cases.
Announcements ORAL ONCOLOGY Date of publication 2019-2
Co-researcher
Education / Career
Article Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to t-cell effector gene expression in non-small-cell lung cancer.
Announcements JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH Date of publication 2019-1
Co-researcher
Education / Career
Article Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis.
Announcements ESMO OPEN Date of publication 2019-1
Co-researcher
Education / Career
Article The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer.
Announcements THORACIC CANCER Date of publication 2019-1
Co-researcher
Education / Career
Article Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
Announcements KOREAN JOURNAL OF INTERNAL MEDICINE Date of publication 2019-1
Co-researcher
Education / Career
Article Significance of f-18-fdg pet parameters according to histologic subtype in the treatment outcome of stage iii non-small-cell lung cancer undergoing definitive concurrent chemoradiotherapy.
Announcements CLINICAL LUNG CANCER Date of publication 2019-1
Co-researcher
Education / Career
Article A phase ii trial of pazopanib in patients with metastatic alveolar soft part sarcoma.
Announcements ONCOLOGIST Date of publication 2019-1
Co-researcher
Education / Career
Article Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors.
Announcements BMC CANCER Date of publication 2019-1
Co-researcher
Education / Career
Article Triumph trial: one small step could become one giant leap for precision oncology in head and neck cancer.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2019-1
Co-researcher
Education / Career
Article The risk of herpes zoster in patients with non-small cell lung cancer according to chemotherapy regimens: tyrosine kinase inhibitors versus cytotoxic chemotherapy.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2019-1
Co-researcher
Education / Career
Article Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2019-1
Co-researcher
Education / Career
Article A phase ii study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer.
Announcements LUNG CANCER Date of publication 2019-0
Co-researcher
Education / Career
Article Bevacizumab plus erlotinib combination therapy for advanced hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma: a multicenter retrospective analysis in korean patients.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2019-0
Co-researcher
Education / Career
Article The prognostic value of albumin-to-alkaline phosphatase ratio before radical radiotherapy in patients with non-metastatic nasopharyngeal carcinoma: a propensity score matching analysis.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2019-0
Co-researcher
Education / Career
Article Inhibition of mek with trametinib enhances the efficacy of anti-pd-l1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma.
Announcements ONCOIMMUNOLOGY Date of publication 2018-9
Co-researcher
Education / Career
Article Pembrolizumab for advanced prostate adenocarcinoma: findings of the keynote-028 study.
Announcements ANNALS OF ONCOLOGY Date of publication 2018-8
Co-researcher
Education / Career
Article Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in keynote-012.
Announcements BRITISH JOURNAL OF CANCER Date of publication 2018-7
Co-researcher
Education / Career
Article Efficacy of bgj398, a fibroblast growth factor receptor 1-3 inhibitor, in patients with previously treated advanced urothelial carcinoma with fgfr3 alterations.
Announcements CANCER DISCOVERY Date of publication 2018-7
Co-researcher
Education / Career
Article Comparison of native escherichia coli l-asparaginase versus pegylated asparaginase in combination with ifosfamide, methotrexate, etoposide, and prednisolone (imep) in extranodal nk/t cell lymphoma, nasal type (ntcl).
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2018-7
Co-researcher
Education / Career
Article The effect of hospice consultation on aggressive treatment of lung cancer.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2018-7
Co-researcher
Education / Career
Article Generalization and representativeness of phase iii immune checkpoint blockade trials in non-small cell lung cancer.
Announcements THORACIC CANCER Date of publication 2018-6
Co-researcher
Education / Career
Article Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: a multicenter retrospective analysis.
Announcements MEDICINE Date of publication 2018-5
Co-researcher
Education / Career
Article Experiences and opinions related to end-of-life discussion: from oncologists' and resident physicians' perspectives.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2018-4
Co-researcher
Education / Career
Article Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-pd-1 antibody.
Announcements CANCER IMMUNOLOGY IMMUNOTHERAPY Date of publication 2018-3
Co-researcher
Education / Career
Article Efficacy of pemetrexed-based chemotherapy in comparison to non-pemetrexed-based chemotherapy in advanced, alk plus non-small cell lung cancer.
Announcements YONSEI MEDICAL JOURNAL Date of publication 2018-3
Co-researcher
Education / Career
Article Pembrolizumab in asia-pacific patients with advanced head and neck squamous cell carcinoma: analyses from keynote-012.
Announcements CANCER SCIENCE Date of publication 2018-3
Co-researcher
Education / Career
Article Cancer pain management education rectifies patients' misconceptions of cancer pain, reduces pain, and improves quality of life.
Announcements PAIN MEDICINE Date of publication 2018-2
Co-researcher
Education / Career
Article Repeat biopsy of patients with acquired resistance to egfr tkis: implications of biopsy-related factors on t790m mutation detection.
Announcements EUROPEAN RADIOLOGY Date of publication 2018-2
Co-researcher
Education / Career
Article Pembrolizumab for the treatment of advanced salivary gland carcinoma: findings of the phase 1b keynote-028 study.
Announcements AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS Date of publication 2018-2
Co-researcher
Education / Career
Article Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (latitude): an international, randomised phase 3 trial.
Announcements LANCET ONCOLOGY Date of publication 2018-2
Co-researcher
Education / Career
Article Intratumoral heterogeneity characterized by pretreatment pet in non-small cell lung cancer patients predicts progression-free survival on egfr tyrosine kinase inhibitor.
Announcements PLOS ONE Date of publication 2018-1
Co-researcher
Education / Career
Article Dabrafenib and trametinib treatment in patients with locally advanced or metastatic braf v600-mutant anaplastic thyroid cancer.
Announcements JOURNAL OF CLINICAL ONCOLOGY Date of publication 2018-1
Co-researcher
Education / Career
Article The impact of skin problems on the quality of life in patients treated with anticancer agents: a cross-sectional study.
Announcements CANCER RESEARCH AND TREATMENT Date of publication 2018-0
Co-researcher
Education / Career
Article Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.
Announcements EUROPEAN RADIOLOGY Date of publication 2017-8
Co-researcher
Education / Career
Article Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Announcements CANCER Date of publication 2017-6
Co-researcher

전체 메뉴

Find a Doctor

Patients

Education &
Research

Information

About SNUH

전체 검색

전체 검색